Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine-assisted low-dose rocuronium for rapid sequence tracheal intubation in children
ChiCTR2500105378Phase 4Not yet recruiting
- Sponsor
- Ganzhou People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Tonsillar hyperplasia and adenoidal hypertrophy (2 arms), sponsored by Ganzhou People's Hospital. Primary endpoint: Tracheal intubation conditions at 90 seconds after rocuronium bromide injection. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Tonsillar hyperplasiaadenoidal hypertrophy
Beyond the preview
Go deeper on ChiCTR2500105378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105378.